Muutke küpsiste eelistusi
  • Formaat - EPUB+DRM
  • Hind: 77,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 230 pages
  • Ilmumisaeg: 28-Jun-2017
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309452083

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 510 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?





Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.

Table of Contents



Front Matter Summary 1 Introduction and Context 2 Emerging Trends and Products of Biotechnology 3 The Current Biotechnology Regulatory System 4 Understanding Risks Related to Future Biotechnology Products 5 Opportunities to Enhance the Capabilities of the Biotechnology Regulatory System 6 Conclusions and Recommendations Glossary Appendix A: Biographical Sketches of Committee Members Appendix B: Agendas of Information-Gathering Sessions Appendix C: Requests for Information Appendix D: Congressionally Defined Product Categories That the U.S. Food and Drug Administration Regulates
1 Front Matter; 2 Summary; 3 1 Introduction and Context; 4 2 Emerging
Trends and Products of Biotechnology; 5 3 The Current Biotechnology
Regulatory System; 6 4 Understanding Risks Related to Future Biotechnology
Products; 7 5 Opportunities to Enhance the Capabilities of the Biotechnology
Regulatory System; 8 6 Conclusions and Recommendations; 9 Glossary; 10
Appendix A Biographical Sketches of Committee Members; 11 Appendix B Agendas
of Information-Gathering Sessions; 12 Appedix C Requests for Information; 13
Appendix D Congressionally Defined Product Categories That the Food and Drug
Administration Regulates